US20050261187A1
University of Texas System
The present invention relates to compositions and methods relating to MEK 5 and its role in heart disease. This protein has now been identified as a target for therapeutic intervention due to its role molecular events that lead to or contribute to cardiac hypertrophy and/or dilated cardiomyopathy.